You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Organizational Factors as Predictors of Tobacco Cessation Pharmacotherapy Adoption in Addiction Treatment Programs

Muilenburg, Jessica L. PhD; Laschober, Tanja C. PhD; Eby, Lillian T. PhD

Journal of Addiction Medicine:
doi: 10.1097/ADM.0000000000000008
Original Research
Abstract

Objectives: This study investigated 3 organizational factors (ie, counseling staff clinical skills, absence of treatment program obstacles, and policy-related incentives) as predictors of tobacco cessation pharmacotherapy (TCP) adoption (comprised of the 9 available TCPs) in addiction treatment programs using the innovation implementation effectiveness framework.

Methods: Data were obtained in 2010 from a random sample of 1006 addiction treatment program administrators located across the United States using structured telephone interviews.

Results: According to program administrator reports, TCP is adopted in approximately 30% of treatment programs. Negative binomial regression results show that fewer treatment program obstacles and more policy-related incentives are related to greater adoption of TCP. Counter to prediction, clinical skills are unrelated to TCP adoption.

Conclusions: Our findings suggest that organizational factors, on the basis of established theoretical frameworks, merit further examination as facilitators of the adoption of diverse TCP in addiction treatment programs.

Author Information

From the Department of Health Promotion and Behavior (JLM), College of Public Health, University of Georgia, Athens, GA; Owens Institute for Behavioral Research (TCL, LTE), Athens, GA; and Industrial-Organizational Psychology Program (LTE), University of Georgia, Athens, GA.

Send correspondence and reprint requests to: Tanja C. Laschober, University of Georgia, 325 Psychology Building, Athens, GA 30602. E-mail: tanja@uga.edu.

Supported by Award Number R01 DA028188 from the National Institute on Drug Abuse (NIDA) awarded to Jessica L. Muilenburg and Lillian T. Eby (multiple principal investigators).

The authors declare no conflicts of interest.

A revised version of this article was presented as part of a symposium at the 2013 Addiction Health Services Research conference.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDA or the National Institutes of Health.

Received May 02, 2013

Accepted October 23, 2013

© 2014 American Society of Addiction Medicine